FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with treating gastric Helicobacter pylori-associated MALT-lymphomas. For this purpose, one should perorally introduce "Vitaflor" preparation as a ferment at daily dosage being not less than 40 g for 4 wk to an empty stomach or in intervals between meals, and in case of no complete regress of lymphoma at monotherapy with "Vitaflor" it is necessary to conduct additional courses of chemotherapy. The method provides cytostatic impact directly upon the tumor and suppresses proliferation of tumoral cells in case of complete absence of chemotherapy-accompanying side effects.
EFFECT: higher efficiency of therapy.
3 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF INFLAMMATORY GASTROINTESTINAL DISEASED ASSOCIATED WITH HELICOBACTER PYLORI | 2004 |
|
RU2278682C2 |
| METHOD FOR MONOTHERAPY OF GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 2020 |
|
RU2758246C1 |
| METHOD OF HELICOBACTER PYLORI INFECTION DIAGNOSTICS IN PATIENTS WITH SURGICAL PATHOLOGY OF ABDOMINAL CAVITY ORGANS | 2009 |
|
RU2440583C2 |
| METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
| METHOD FOR TREATING INFLAMMATORY DEGENERATIVE STOMACH AND DUODENUM DISEASES | 2005 |
|
RU2289448C1 |
| METHOD FOR HELICOBACTER PYLORI ERADICATION OF GASTRODUODENAL ZONE | 2014 |
|
RU2545687C1 |
| METHOD OF CHILDREN TREATMENT SUFFERING FROM SUPERIOR DIGESTIVE DISORDERS ASSOCIATED WITH HELICOBACTER PYLORI | 2006 |
|
RU2328296C2 |
| METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
| METHOD OF MEDICAL TREATMENT OF DUODENAL ULCER ASSOCIATED WITH Helicobacter pylori | 2006 |
|
RU2325918C2 |
| METHOD FOR PREVENTING EROSIVE AND ULCERATIVE LESIONS OF STOMACH AND DUODENUM DURING CHEMOTHERAPY | 2023 |
|
RU2806313C1 |
